You have probably seen the marketing claim: “Take NMN, feel younger, feel more energetic.” It is a tidy promise. The biology underneath it is messier, and a lot more interesting. If you came to NMN hoping for a clean energy boost the way coffee delivers one, you deserve a straight answer about what the mitochondrial evidence shows, and what it does not.
This article walks through the chain from NAD+ to mitochondrial output, looks honestly at the human trial that energy claims usually rest on, and helps you decide whether NMN is worth trying for fatigue, given your own daily reality.
The NAD+ to mitochondria chain
Every cell in your body runs on ATP, the molecular currency of energy. ATP is produced mainly inside mitochondria. To make ATP efficiently, mitochondria depend on a coenzyme called NAD+, which shuttles electrons through the electron transport chain.
Here is the catch. NAD+ levels decline with age. Verdin’s 2015 review in Science laid out how falling NAD+ tracks with reduced mitochondrial function, impaired DNA repair, and the broader metabolic slowdown that defines biological ageing. Rajman, Chwalek, and Sinclair’s 2018 review in Cell Metabolism extended this picture, arguing that NAD+ precursors are among the most credible candidates for clinically translatable longevity interventions.
NMN converts to NAD+ once absorbed, raising the substrate pool that mitochondria draw on. That is the theoretical case for energy benefits. Whether it translates into you feeling less tired at 3pm is a separate question.
What the mouse data showed
The strongest preclinical signal came from Mills and colleagues in 2016. Long-term NMN administration in mice mitigated age-associated declines in physical activity, energy expenditure, and insulin sensitivity. Mitochondrial oxidative metabolism improved measurably. This is the study that launched the modern NMN field.
Mice are not humans, and lab conditions are not Kuala Lumpur traffic. But the mouse work was the trigger for human trials, and Yoshino’s 2018 review synthesised the rationale: NAD+ precursors consistently improved metabolic and mitochondrial parameters across rodent models.
The Liao 2021 runners trial, read carefully
The most cited human energy study is Liao et al. (2021). Forty-eight amateur runners took NMN at varying doses for six weeks alongside a structured training programme. The headline finding: aerobic capacity, measured as ventilatory thresholds during cycling ergometer tests, improved dose-dependently in NMN groups compared with placebo. VO2 max itself did not significantly differ, but the ventilatory thresholds did.
Read that carefully. The participants were already training. The benefit appeared in trained, active people doing structured aerobic work. It was not a study of office workers feeling tired after lunch. For broader benefit claims, see benefits.
Older adults: a different signal
Igarashi et al. (2022) ran a placebo-controlled trial in older Japanese men. Twelve weeks of NMN at 250mg daily improved muscle performance and gait speed compared with placebo, particularly in afternoon dosing. This is a more directly relevant signal for sedentary readers who simply want to function better through the day.
Subjective energy versus objective markers
Across the human NMN literature, objective markers - ventilatory thresholds, walking speed, blood NAD+ levels - are what move most reliably. Subjective fatigue scores are noisier. Some participants report feeling more energetic. Others report nothing. Placebo effects in supplement trials are real.
If you are a Malaysian gym-goer doing four sessions a week, the runners trial offers a plausible reason to expect modest aerobic benefit at the right dosage. If you are an office worker logging ten thousand steps a day at most, the Igarashi-style functional improvements are a more realistic frame than “I will feel like I did at twenty-five.”
Why context matters for the Malaysian reader
Sleep debt, irregular meals, sedentary work, and chronic low-grade dehydration produce most of the fatigue you feel during a working week in Petaling Jaya or Penang. NMN does not fix any of those. If your NAD+ is low because you sleep five hours a night and survive on teh tarik, raising NAD+ with a supplement is patching one input while three others bleed.
The fairest framing: NMN may modestly support mitochondrial function, particularly when stacked with exercise and reasonable lifestyle inputs. It is not a fatigue cure. For the deeper mechanistic background, see science.
Bottom line for Malaysian readers
NMN does not deliver coffee-style alertness. It may modestly improve aerobic capacity in trained adults and walking speed/grip strength in older men, over 6-12 weeks of consistent dosing. It will not fix fatigue caused by poor sleep, sedentary days, and overstimulation by caffeine. Use objective markers - exercise tolerance, recovery, blood markers if you have them - to decide if it is working for you.